Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth CorpfiledCriticalWyeth Corp
Priority to CR9091ApriorityCriticalpatent/CR9091A/en
Publication of CR9091ApublicationCriticalpatent/CR9091A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
La presente invencion provee formulaciones de dosificacion solidas de derivados de [1,4]diazepino[6,7,1-ij)quinolina, y procedimientos para su fabricacion, en algunas modalidades particulares, la presente invencion provee formulaciones novedosas del agente antipsicotico y antiobesidad clorhidrato de (9aR,12aS)-4,5,6,7,9,9a,10,11,12,12a-decahidrociclopenta[c][1,4]diazepino[6,7,1-ij]quinolina, es decir, clorhidrato del compuesto A.The present invention provides solid dosage formulations of [1,4] diazepine [6,7,1-ij) quinoline derivatives, and methods for their manufacture, in some particular embodiments, the present invention provides novel formulations of the antipsychotic and antiobesity agent (9aR, 12aS) -4,5,6,7,9,9a hydrochloride, 10,11,12,12a-decahydrocyclopenta [c] [1,4] diazepino [6,7,1-ij] quinoline, is that is, compound A hydrochloride.
CR9091A2007-05-022007-05-02
FORMULATIONS OF DERIVATIVES FORMULATIONS OF DERIVATIVES OF [1,4] DIAZEPINO [6,7,1IJ] QUINOLINA
CR9091A
(en)
Compounds derived from imidazo [1,2-b] pyridazines, kinase inhibitors; process of preparing said compounds; pharmaceutical composition that includes them; its preparation process; and its use in hyperproliferative, inflammatory, allergic and obstructive diseases of the respiratory tract, among others.
3-(1,3-benzoxazol-5-yl)-pyrazolo[3,4-d]pyrimidin-4-amine derivative, a pharmaceutical composition and the use of the derivative for the manufacture of a medicament
Compounds derived from imidazol [1,2-a] pyrazin-8-amine, splenic tyrosine kinase inhibitors; pharmaceutical composition comprising a compound; use of the compounds in the preparation of medicaments for the treatment of allergic disorders, autoimmune diseases and inflammatory diseases; and in vitro method.
Compounds derived from 1h-pyrazolo [4,3-c] quinolin-4 (5h) -one, phosphodiestera 9 inhibitors (pde9); pharmaceutical composition that includes them; and agent to improve cognitive impairment in Alzheimer's disease.
Use of a pharmaceutical combination of a compound derived from thieno [3,2-d] pyrimidine with a chemotherapeutic agent in the treatment of a hyperproliferative disorder; pharmaceutical kit.
Compounds derived from methanopyrazolo [3,4-e] [1,3] diazepine; preparation procedure; pharmaceutical composition comprising them; and its use in the treatment of bacterial infections.
Derivatives of pyrazolo[1,5-a]pyrimidin-7-ylamine substituted by halogen in position 6 and by (1- or 2-)methylpyrazol-4-yl in position 3, and pharmaceutical compositions comprising same
1,2,3,4-TETRAHYDROPYRROLO [1,2-A] PYRAZINE-6-CARBOXAMIDES AND 2,3,4,5-TETRAHYDROPYRROLO [1,2-A] [1,4] -DIAZEPINE-7 DERIVATIVES -CARBOXAMIDES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION